தானியங்கி பத்திரங்கள் மனநிலை திட்டங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Mar 29, 2021     CAMBRIDGE, Mass. & MONTREAL (BUSINESS WIRE) Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that each of its Executive Vice President and Chief Financial Officer, Steve Forte and its Executive Vice President and Chief Medical Officer, Maria Koehler (collectively, the “Executives”), have established Automatic Securities Disposition Plans (“ASDPs”) in accordance with applicable United States and Canadian securities legislation, including U.S. Securities and Exchange Commission (“SEC”) rule 10b5-1 and the recommended practices set forth in the recently issued Canadian Securities Administrators’ Staff Notice 55-317 (“Staff Notice 55-317”) and the Company’s internal policies.

United statesUnited kingdomMaria koehlerSteve forteExchange commissionCompany nasdaqRepare therapeutics incExecutive vice presidentChief financial officerChief medical officerAutomatic securities disposition plansCanadian securities administrator staff noticeNasdaq global select marketSecurities actCanadian securities administratorsStaff notice